About Bioexpert Network
Bioexpert Network was started in 2017 and is owned by Capital Cell, an alternative investment platform for life sciences and biotech based in Barcelona. Rather than a fee-for-service expert network that clients pay to access, BEN is an invite-only community of life sciences experts - PhD-level scientists, physicians, biotech entrepreneurs, and industry consultants - who evaluate startup pitch decks and R&D proposals submitted to Capital Cell's crowdfunding platform. Experts review each proposal's science, team, and business potential, and only the most positively reviewed projects move forward to a public crowdfunding campaign on Capital Cell. In exchange for reviewing, experts can earn investment credits they can use to invest in the companies they've evaluated, rather than being paid a consulting fee.
Curious to learn a bit more about the different expert network business models? Check out our blog.
BEN's focus areas are within life sciences - medical devices, pharmaceuticals, biotechnology, and diagnostics - a specialization it shares with more conventional fee-based networks like Techspert.io, Experts OnTap, Atheneum, and IDR - though those firms operate on a standard paid-consultation model, unlike BEN.
FAQ
Bioexpert Network specializes in life sciences expert review - medical devices, pharmaceuticals, biotechnology, and diagnostics - though it doesn't operate as a "traditional" expert network. It's a community of experts who evaluate startup proposals for Capital Cell's crowdfunding platform, earning investment credits rather than consulting fees.
No - Bioexpert network is not part of the Inex One marketplace.
